https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47071 Tue 13 Dec 2022 16:14:28 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44140 P = 0.024). Overweight patients were more frequently underdosed compared to non-overweight patients (P = 0.039). The frequency and proportion of underdosing increased with BMI. Overweight patients spent a smaller fraction of their course within the therapeutic range, although the difference was not statistically significant (difference 7.7%; 95% CI 4% to 19.4%; P = 0.195). The overweight group had longer hospital length of stay (LOS), higher mortality and more treatment failures. Conclusion: Adherence to guideline-based prescription is poor, particularly in overweight patients. Patients who are initially underdosed have fewer therapeutic vancomycin days, regardless of BMI. Overweight patients have increased hospital LOS, hospital mortality and treatment failure.]]> Sat 08 Oct 2022 12:43:32 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:40036 Fri 15 Jul 2022 12:58:16 AEST ]]>